The Board of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. proposed a final dividend for the year ended 31 December 2021, before tax, amounted to RMB 0.56 per share, which is subject to the approval of the Shareholders at the forthcoming annual general meeting (the AGM'). Subject to the approval of the Shareholders at the AGM, the 2021 Final Dividend is expected to be paid to the eligible Shareholders by no later than 31 August 2022. Record date is March 22, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.1 CNY | -0.43% | -2.86% | -7.71% |
15/05 | Fosun Pharma Unit Fosun Health to Receive Capital Injection from Foshan Chanxi City Investment | MT |
15/05 | China Approves Clinical Trials For Breast Cancer Drugs | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.71% | 7.66B | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Shanghai Fosun Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year Ended 31 December 2021